| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |